OlarteMoure
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
OlarteMoure’s comprehensive life sciences offering attracts praise for its ‘ability to solve cases and propose alternatives’. The team is particularly distinguished by its deep bench, which leverages five partners and 22 additional lawyers dedicated to supporting clients in the life sciences industries. Combining the firm’s signature skill sets in IP and regulation, the practice advises on the full spectrum of related work, including patents, litigation (including compulsory licensing defence), transactional matters and compliance. Key figures include senior partner Carlos Olarte, who is also a qualified biomedical and mechanical engineer. Olarte specialises in patent drafting, prosecution and litigation, and recently acted in conjunction with patent head Mónica Guevara to advise Velvack Panacea on multi-jurisdictional patent strategy. Catalina Jiménez Abadía, who spearheads the compliance division, is also recommended at partner level. The department further benefits from a deep pool of non-partners, which includes patent litigation director Liliana Galindo, who has experience in compulsory licence litigation; and qualified lawyer and pharmaceutical chemist Mauricio Ávila, who was promoted to director of the regulatory affairs unit in January 2025. Former regulatory affairs head Alexander Agudelo left the firm in June 2025.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team stands out for its knowledge of the area of expertise and ability to solve cases and propose alternatives.’
‘Lawyers bring excellent knowledge of the practice area and timely responses to client requirements.’
Key clients
- Bristol-Myers Squibb
- Merck & Co.
Work highlights
Advising Bristol-Myers Squibb on IP prosecution in Latin America.
